Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity

Patent metadata

Field	Value
Publication number	US-10239936-B2
Application number	US-201615052986-A
Country	US
Kind code	B2
Filing date	Feb 25, 2016
Priority date	Aug 2, 2006
Publication date	Mar 26, 2019
Grant date	Mar 26, 2019

Abstract

Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs). More particularly, disclosed are a variety of antigen specific polypeptides, including soluble, monoclonal, and multivalent forms, as well as methods of using the polypeptides, antibodies that bind the antigen specific polypeptides, and nucleic acids, vectors and expression systems that encode the polypeptides. Antigen specific polypeptides that selectively bind pathogens, like anthrax, and carbohydrates, like blood group determinants, are specifically disclosed.

First claim

What is claimed is:

1. A method of making a plurality of purified multimers comprising a plurality of soluble, monoclonal antigen specific polypeptides comprising
a) isolating a cDNA clone encoding an antigen specific polypeptide, wherein the antigen specific polypeptide comprises an N-terminal leucine rich repeat (LRRNT), one or more leucine rich repeats (LRRs), a C-terminal leucine rich repeat (LRRCT), and a connecting peptide, wherein the connecting peptide comprises an alpha helix;
b) transfecting a mammalian cell in culture medium with the cDNA clone of step (a); and
c) isolating the plurality of multimers from the culture medium.

2. The method of claim 1 , wherein the antigen specific polypeptides bind a target protein, a target carbohydrate or a target pathogen.

3. The method of claim 1 , further comprising the step of generating a stable mammalian cell line comprising the cDNA clone.

Assignees

• Uab Res Found

Inventors

• Cooper Max D
• Herrin Brantley R
• Alder Matthew N

Classifications

• A61P31/18

  for HIV · CPC title

• A61P31/16

  for influenza or rhinoviruses · CPC title

• A61P31/12

  Antivirals · CPC title

• C07K2317/14

  Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title

• C07K2317/33

  Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity · CPC title